Slide 1: Investor Presentation – TechKnow Invest Roadshow
For personal use only Investor Presentation — TechKnow Invest Roadshow 1-3 August 2023 ASX: AUA Approved for release by the Board of Audeara Limited.
Slide 2: Disclaimer | Important information
Disclaimer | Important information For personal use only 1 August 2023 This presentation has been prepared by Audeara Limited ACN 604 368 443 (Company) for the sole purpose of providing the Recipient with general information only. This presentation does not purport to be complete, nor does it contai
Slide 3: Business overview
Business overview For personal use only Audeara AUA Technology Headphone and accessories sales: Audeara ▸ White label products for large third ▸ Partnerships with domestic and parties Proprietary Technology international audiology clinic ▸ Highly scalable technology licensing chains Hardware | Firmw
Slide 4: Record financial results and strong operational performance
Record financial results and strong operational performance For personal use only ▸ Quarterly revenue of $0.94m - up 23% yoy (Q4 FY22: $0.76m) and 40% qoq (Q3 FY23: $0.67m) ▸ Q4 FY23 cash receipts of $0.59m with an additional $0.38m received post quarter end ▸ Revenue and cash receipts underpinned b
Slide 5: Sales by Half Year continue to diversify
Sales by Half Year continue to diversify For personal use only Australian Wholesale ▸ Focus on increasing sales per clinic AUA Technology ▸ Engineering Services International Wholesale ▸ EU - global chains ▸ US - Independents, global chains ▸ Taiwan - Clinico Australian Retail ▸ NDIS + E-Commerce
Slide 6: Audeara: Hardware and software solutions for the hearing industry
For personal use only Audeara Hardware and software solutions for the hearing industry
Slide 7: The Audeara difference / Who is Audeara for?
The Audeara difference Who is Audeara for? For personal use only Audeara is for people of all hearing abilities. The primary end users of our products are people who Audeara headphones use are seeking solutions in an audiology clinic setting who fit into these groups: a hearing check algorithm^ to t
Slide 8: Clients | Audiology clinics
Clients | Audiology clinics For personal use only The PROBLEM for audiology clinics The SOLUTION of Audeara to audiology clinics 45% Additional revenue stream of self declared hearing impaired adopt hearing As an Assistive Listening Device (ALD), Audeara provides clinics with aids* an additional rev
Slide 9: Clients | Audiology clinics
Clients | Audiology clinics For personal use only Australia Audeara’s Number of locations that currently stock international opportunities Audeara (including sub-brands) (including sub-brands) ~9,241 locations# By 2030, nearly 645# in 25 countries 1 2,119.1 million EUR Consolidated 1.9 Revenue 1 ~2,
Slide 10: International distribution
International distribution An established footprint and near term international expansion opportunities For personal use only ASIAPAC Australia ▸ Currently stocked in over 1400 clinics. ▸ Primary revenue stream FY23 Currently stocked in 7 countries Taiwan ▸ Currently stocked in Clinico Inc. clinics
Slide 11: AUA Technology
For personal use only AUA Technology Innovative listening solutions with the potential to unlock a new, high margin licensing and contract manufacturing revenue stream
Slide 12: AUA Technology: Third party product development and technology licensing
AUA Technology For personal use only Third party product development and technology licensing Leverage Audeara Proprietary Technology for strategic opportunities outside of audiology industry. Audeara product pipeline Utilise Audeara Proprietary Technology to develop products in Audeara’s product pi
Slide 13: Taiwan's largest hearing aid retailer Clinico Inc.
Taiwan’s largest hearing aid retailer Clinico Inc. For personal use only Cooperative agreement following strategic $2.8M investment at 20% premium Product development Exclusive distribution Developing a series of healthy In Taiwan and China, Audeara will Clinico Inc. is a Taiwanese company, hearing
Slide 14: Global musical instrument brand
Global musical instrument brand For personal use only Product development agreement Engineering fee for services Contract manufacturing and underway licensing H1 FY24 ▸ Design High volume consumer markets ▸ Sourcing with global reach ▸ Product development Highly scalable products with well establish
Slide 15: Innovative product pipeline
Innovative product pipeline For personal use only Tailored listening software ▸ Audeara app (consumer mobile app) Headphones with tailored sound ▸ AudAssist (desktop app for clinics) A-01 Headphones A-02 Headphones A-03 Headphones Kids Research and development underway ▸ Musicians ▹ Hearing protecti
Slide 16: Outlook
For personal use only Outlook
Slide 17: Milestones and targets 2023 - 2024
Milestones and targets 2023 - 2024 For personal use only Current quarter FY24 targets April - June ▸ Australian wholesale driven Audeara record quarter ▸ EU Global Clinic Groups ▹ 10 European countries ▸ WS Audiology Austria ▸ US Global Clinic Groups ▹ Expansion beyond trial ▸ WS Audiology USA sites
Slide 18: Contact
For personal use only Contact INVESTOR ENQUIRIES Dr James Fielding Managing Director and Chief Executive Officer james.fielding@audeara.com
Slide 19: Company snapshot
Company snapshot For personal use only Enterprise value (A$) Top shareholders Share price $0.032 Name Shares Percentage Market cap $4.59M at 30 June 2023 Fortune Pioneer 28,000,000 19.5% Cash As at 30 June 2023 $2.62M Board of Directors 43,515,087 30.0% Debt As at 30 June 2023 $0 Other Top 20 31,302
Slide 20: Board Members
Board Members For personal use only Dr. James Fielding David Trimboli Pasquale ‘Paddy’ Rombola Dr. Elaine Saunders Bill Peng CEO and Managing Director Non-Executive Chairman Non-Executive Director Non-Executive Director Executive Director Dr Fielding completed dual bachelor’s Mr Trimboli helped laun